Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Medite Cancer Diagnostics, Inc. | mdit10q_mar312016.htm |
| EX-31.2 - Medite Cancer Diagnostics, Inc. | ex31-2.htm |
| EX-31.1 - Medite Cancer Diagnostics, Inc. | ex31-1.htm |
| EX-32.2 - Medite Cancer Diagnostics, Inc. | ex32-2.htm |
Exhibit 32.1
CERTIFICATIONS PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of MEDITE CANCER DIAGNOSTICS, INC. (the “Company”) on Form 10-Q for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michaela Ott, as Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|
|
By:
|
/s/ Michaela Ott
|
Dated:
|
May 13, 2016
|
|
Michaela Ott
|
|||
|
Title:
|
Chief Executive Officer
(Principal Executive Officer)
|
||